Target Extracellular traps
(Unterschied zwischen Versionen)
| Zeile 1: | Zeile 1: | ||
{{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}} | {{tp|p=32302401|t=2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps |pdf=|usr=}} | ||
{{tp|p=32355564|t=2020. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome |pdf=|usr=}} | {{tp|p=32355564|t=2020. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome |pdf=|usr=}} | ||
| + | {{tp|p=32505910|t=2020. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1beta/neutrophil extracellular traps feedback loop.|pdf=|usr=007}} | ||
Version vom 28. Juni 2020, 09:33 Uhr
32302401 2020. Targeting potential drivers of COVID-19: Neutrophil extracellular traps
32355564 2020. Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
32505910 2020. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1beta/neutrophil extracellular traps feedback loop.
